Albert Bourla Discusses COVID-19 Vaccine Efficacy Results

Pfizer and collaborator, BioNTech, announced positive efficacy results from our Phase 3, late-stage study of our potential COVID-19 vaccine.

COVID-19 Vaccine Development

Rapid progress on the path to develop, test and manufacture a vaccine.

Coronavirus COVID-19 Resource Center

As the coronavirus disease (COVID-19) continues to spread, at Pfizer, we are committed to ensuring public health and safety for our colleagues, retirees, and global patient community. Learn more about COVID-19 and what you can do to stay safe and prevent the spread of this infectious disease.

COVID-19 Temporary Benefits Coverage Enhancements for U.S. Retirees

As the concerns of the COVID-19 virus impact our daily lives, Pfizer has reviewed its U.S. medical plans to make it easier and less costly for retirees to receive the medical care, including testing for COVID-19, they may need.

Join the Pfizer Plus Community Corner

When you join the community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • Community